Robert R. Olander

Alto Ingredients, Inc.Alto Ingredients, Inc.

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 1 buy · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€9,339

▼ Sales (0 ops.)

—

Latest filing published 03 Apr 2026 for Alto Ingredients, Inc., €170k. Read the official filing

Filing timeline

BuySale

Robert R. Olander

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Alto Ingredients, Inc. 1 purchase · last 13 Nov 2024

Robert R. Olander: trading record in brief

Robert R. Olander appears in our data through filings on Alto Ingredients, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 17 September 2023 to 1 April 2026, the count stands at 7 filings.

The open-market record is one-sided, with 1 purchase worth €9,339 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 6 share grants.

Most recently, on 3 April 2026, the filings show a share grant worth €170k in Alto Ingredients, Inc. The last purchase on record was published on 13 November 2024, which is 704 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.